Ophir Clinical Research is an investigator-led clinical research site dedicated to the successful execution of Phase II–IV clinical trials. We work closely with sponsors and CROs to deliver reliable site performance, regulatory compliance, and high-quality clinical data.
Our team is committed to conducting research with integrity, precision, and patient safety at the forefront. From study start-up through close-out, we follow ICH-GCP–compliant processes to ensure ethical study conduct, accurate data collection, and inspection readiness at every stage.
By combining strong medical oversight with efficient site operations and participant-focused care, Ophir Clinical Research serves as a dependable partner in advancing clinical development.
To advance clinical research through ethical conduct, regulatory compliance, and compassionate participant care, supporting sponsors and CROs in the development of safe and effective therapies.
To be a trusted clinical research site recognized for data quality, operational excellence, and participant-focused research practices.
At Ophir Clinical Research, our work is guided by a structured, compliance-driven approach
Every study is conducted under direct Principal Investigator leadership, ensuring consistent medical oversight and safety monitoring.
Our processes are aligned with global regulatory standards to support ethical study conduct and inspection readiness.
We prioritize informed consent, education, and respectful engagement to support participant safety and retention.
Clear communication, timely query resolution, and organized documentation define our partnerships.